Every source in the book

The Energy Guidebook, Fifth Edition, cites 451 references across eleven parts. They are listed here as they appear in the book. Each has a Find link that searches Google Scholar for it.

451 references
Part One Why This Works When Diets Don’t 19
  1. Emmerich SD, Fryar CD, Stierman B, Ogden CL. Obesity and severe obesity prevalence in adults: United States, August 2021–August 2023. NCHS Data Brief No. 508. Hyattsville, MD: National Center for Health Statistics; 2024. doi:10.15620/cdc/159281.
  2. Centers for Disease Control and Prevention. National Diabetes Statistics Report (data for 2021). Atlanta, GA: US Department of Health and Human Services; updated September 2026.
  3. Araújo J, Cai J, Stevens J. Prevalence of optimal metabolic health in American adults: National Health and Nutrition Examination Survey 2009–2016. Metabolic Syndrome and Related Disorders. 2019;17(1):46–52.
  4. Wing RR, Phelan S. Long-term weight loss maintenance. American Journal of Clinical Nutrition. 2005;82(1 Suppl):222S–225S.
  5. Sievert K, Hussain SM, Page MJ, et al. Effect of breakfast on weight and energy intake: systematic review and meta-analysis of randomised controlled trials. BMJ. 2019;364:l42.
  6. Dansinger ML, Gleason JA, Griffith JL, Selker HP, Schaefer EJ. Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA. 2005;293(1):43–53.
  7. Gardner CD, Trepanowski JF, Del Gobbo LC, et al. Effect of low-fat vs low-carbohydrate diet on 12-month weight loss in overweight adults and the association with genotype pattern or insulin secretion: the DIETFITS randomized clinical trial. JAMA. 2018;319(7):667–679.
  8. Killer SC, Blannin AK, Jeukendrup AE. No evidence of dehydration with moderate daily coffee intake: a counterbalanced cross-over study in a free-living population. PLoS One. 2014;9(1):e84154.
  9. Reynolds A, Mann J, Cummings J, Winter N, Mete E, Te Morenga L. Carbohydrate quality and human health: a series of systematic reviews and meta-analyses. Lancet. 2019;393(10170):434–445.
  10. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999;354(9188):1435–1439.
  11. Nedeltcheva AV, Kilkus JM, Imperial J, Schoeller DA, Penev PD. Insufficient sleep undermines dietary efforts to reduce adiposity. Annals of Internal Medicine. 2010;153(7):435–441.
  12. Holt-Lunstad J, Smith TB, Layton JB. Social relationships and mortality risk: a meta-analytic review. PLoS Medicine. 2010;7(7):e1000316.
  13. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. New England Journal of Medicine. 1994;330(15):1029–1035.
  14. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. New England Journal of Medicine. 1996;334(18):1150–1155.
  15. Klein EA, Thompson IM, Tangen CM, et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2011;306(14):1549–1556.
  16. Ristow M, Zarse K, Oberbach A, et al. Antioxidants prevent health-promoting effects of physical exercise in humans. Proceedings of the National Academy of Sciences. 2009;106(21):8665–8670.
  17. Berthold HK, Unverdorben S, Degenhardt R, Bulitta M, Gouni-Berthold I. Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial. JAMA. 2006;295(19):2262–2269.
  18. Ried K, Toben C, Fakler P. Effect of garlic on serum lipids: an updated meta-analysis. Nutrition Reviews. 2013;71(5):282–299.
  19. Gardner CD, Lawson LD, Block E, et al. Effect of raw garlic vs commercial garlic supplements on plasma lipid concentrations in adults with moderate hypercholesterolemia: a randomized clinical trial. Archives of Internal Medicine. 2007;167(4):346–353.
Part Two Know Your Starting Point 38
  1. Nana A, Slater GJ, Stewart AD, Burke LM. Methodology review: using dual-energy X-ray absorptiometry (DEXA) for the assessment of body composition in athletes and active people. International Journal of Sport Nutrition and Exercise Metabolism. 2015;25(2):198–215.
  2. Frija-Masson J, Mullaert J, Vidal-Petiot E, Pons-Kerjean N, Flamant M, d’Ortho MP. Accuracy of smart scales on weight and body composition: observational study. JMIR mHealth and uHealth. 2021;9(4):e22487. doi:10.2196/22487.
  3. Jackson AS, Pollock ML. Generalized equations for predicting body density of men. British Journal of Nutrition. 1978;40(3):497–504.
  4. Jackson AS, Pollock ML, Ward A. Generalized equations for predicting body density of women. Medicine and Science in Sports and Exercise. 1980;12(3):175–181.
  5. Tinsley GM, Moore ML, Benavides ML, Dellinger JR, Adamson BT. Digital anthropometry via three-dimensional optical scanning: evaluation of four commercially available systems. European Journal of Clinical Nutrition. 2020;74(7):1054–1064.
  6. Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obesity Reviews. 2012;13(3):275–286.
  7. Ashwell M, Gibson S. Waist-to-height ratio as an indicator of “early health risk”: simpler and more predictive than using a “matrix” based on BMI and waist circumference. BMJ Open. 2016;6(3):e010159.
  8. National Institute for Health and Care Excellence. Overweight and obesity management. NICE guideline NG246, 14 January 2025 (replaces CG189). London: NICE. www.nice.org.uk/guidance/ng246.
  9. Lohman TG. Advances in Body Composition Assessment. Champaign, IL: Human Kinetics; 1992. Classification bands as tabulated in Jeukendrup A, Gleeson M. Sport Nutrition. 3rd ed. Champaign, IL: Human Kinetics; 2019.
  10. Gallagher D, Heymsfield SB, Heo M, Jebb SA, Murgatroyd PR, Sakamoto Y. Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. American Journal of Clinical Nutrition. 2000;72(3):694–701.
  11. McArdle WD, Katch FI, Katch VL. Exercise Physiology: Nutrition, Energy, and Human Performance. 8th ed. Philadelphia: Wolters Kluwer Health; 2015.
  12. Mountjoy M, Ackerman KE, Bailey DM, et al. 2023 International Olympic Committee’s (IOC) consensus statement on Relative Energy Deficiency in Sport (REDs). British Journal of Sports Medicine. 2023;57(17):1073–1097.
  13. Sniderman AD, Thanassoulis G, Glavinovic T, et al. Apolipoprotein B particles and cardiovascular disease: a narrative review. JAMA Cardiology. 2019;4(12):1287–1295.
  14. Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias. European Heart Journal. 2020;41(1):111–188; and 2025 Focused Update. European Heart Journal. 2025;46(42):4359.
  15. Soffer DE, Marston NA, Maki KC, et al. Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: an Expert Clinical Consensus from the National Lipid Association. Journal of Clinical Lipidology. 2024;18(5):e647–e663.
  16. Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol. Circulation. 2019;139(25):e1082–e1143. Coronary artery calcium scoring is a Class IIa recommendation for adults 40–75 at intermediate risk, or at borderline risk with risk-enhancing factors, when the statin decision is uncertain.
  17. Ference BA, Ginsberg HN, Graham I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. European Heart Journal. 2017;38(32):2459–2472.
  18. Tsimikas S, Fazio S, Ferdinand KC, et al. NHLBI Working Group recommendations to reduce lipoprotein(a)-mediated risk of cardiovascular disease and aortic stenosis. Journal of the American College of Cardiology. 2018;71(2):177–192.
  19. Ridker PM, Moorthy MV, Cook NR, Rifai N, Lee IM, Buring JE. Inflammation, cholesterol, lipoprotein(a), and 30-year cardiovascular outcomes in women. New England Journal of Medicine. 2024;391:2087–2097.
  20. American Diabetes Association Professional Practice Committee. 2. Diagnosis and classification of diabetes: Standards of Care in Diabetes, 2026. Diabetes Care. 2026;49(Suppl 1).
  21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–419.
  22. McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G. Use of metabolic markers to identify overweight individuals who are insulin resistant. Annals of Internal Medicine. 2003;139(10):802–809.
  23. Sumner AE, Finley KB, Genovese DJ, Criqui MH, Boston RC. Fasting triglyceride and the triglyceride–HDL cholesterol ratio are not markers of insulin resistance in African Americans. Archives of Internal Medicine. 2005;165(12):1395–1400.
  24. Robbins R, Weaver MD, Sullivan JP, et al. Accuracy of three commercial wearable devices for sleep tracking in healthy adults. Sensors. 2024;24(20):6532.
  25. Buchheit M. Monitoring training status with HR measures: do all roads lead to Rome? Frontiers in Physiology. 2014;5:73.
  26. Shaffer F, Ginsberg JP. An overview of heart rate variability metrics and norms. Frontiers in Public Health. 2017;5:258.
  27. Ramos-Campo DJ, Medellín Ruiz JP, Rubio-Arias JÁ, Clemente-Suárez VJ. Effectiveness of training prescription guided by heart rate variability versus predefined training for physiological and aerobic performance improvements: a systematic review and meta-analysis. Applied Sciences. 2020;10(23):8532.
  28. Baron KG, Abbott S, Jao N, Manalo N, Mullen R. Orthosomnia: are some patients taking the quantified self too far? Journal of Clinical Sleep Medicine. 2017;13(2):351–354.
  29. US Food and Drug Administration. FDA clears first over-the-counter continuous glucose monitor. Press announcement, 5 March 2024.
  30. Hall H, Perelman D, Breschi A, et al. Glucotypes reveal new patterns of glucose dysregulation. PLoS Biology. 2018;16(7):e2005143.
  31. Locke EA, Latham GP. Building a practically useful theory of goal setting and task motivation: a 35-year odyssey. American Psychologist. 2002;57(9):705–717.
  32. Gollwitzer PM, Sheeran P. Implementation intentions and goal achievement: a meta-analysis of effects and processes. Advances in Experimental Social Psychology. 2006;38:69–119.
  33. Harkin B, Webb TL, Chang BPI, et al. Does monitoring goal progress promote goal attainment? A meta-analysis of the experimental evidence. Psychological Bulletin. 2016;142(2):198–229.
  34. Lally P, van Jaarsveld CHM, Potts HWW, Wardle J. How are habits formed: modelling habit formation in the real world. European Journal of Social Psychology. 2010;40(6):998–1009.
  35. Demay MB, Pittas AG, Bikle DD, et al. Vitamin D for the prevention of disease: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism. 2024;109(8):1907–1947.
  36. Ramsis M, Naguib M, Dzotsi M, et al. Lipoprotein(a) testing trends in the United States 2015–2024: an analysis of 300 million individuals. JACC: Advances. 2025;4(11):102205.
  37. Koschinsky ML, Bajaj A, Boffa MB, et al. A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice. Journal of Clinical Lipidology. 2024;18(3):e308–e319.
  38. O’Donoghue ML, Fazio S, Giugliano RP, et al. Lipoprotein(a), PCSK9 inhibition, and cardiovascular risk. Circulation. 2019;139(12):1483–1492.
Part Three Nutrition (Essential 1) 110
  1. American Diabetes Association. “Postprandial Blood Glucose.” Diabetes Care 2001;24(4):775–778; and American Diabetes Association Professional Practice Committee. “2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes, 2026.” Diabetes Care 2026;49(Suppl 1).
  2. Holst JJ, Wewer Albrechtsen NJ, Pedersen J, Knop FK. “Glucagon and Amino Acids Are Linked in a Mutual Feedback Cycle: The Liver–α-Cell Axis.” Diabetes 2017;66(2):235–240.
  3. Jensen MD, Caruso M, Heiling V, Miles JM. “Insulin regulation of lipolysis in nondiabetic and IDDM subjects.” Diabetes 1989;38(12):1595–1601.
  4. Campbell PJ, Carlson MG, Hill JO, Nurjhan N. “Regulation of free fatty acid metabolism by insulin in humans: role of lipolysis and reesterification.” American Journal of Physiology 1992;263(6 Pt 1):E1063–E1069.
  5. Hall KD, Chen KY, Guo J, et al. “Energy expenditure and body composition changes after an isocaloric ketogenic diet in overweight and obese men.” American Journal of Clinical Nutrition 2016;104(2):324–333.
  6. Hall KD, Guo J, Courville AB, et al. “Effect of a plant-based, low-fat diet versus an animal-based, ketogenic diet on ad libitum energy intake.” Nature Medicine 2021;27:344–353.
  7. Wyatt P, Berry SE, Finlayson G, et al. “Postprandial glycaemic dips predict appetite and energy intake in healthy individuals.” Nature Metabolism 2021;3:523–529.
  8. Berry SE, Valdes AM, Drew DA, et al. “Human postprandial responses to food and potential for precision nutrition.” Nature Medicine 2020;26:964–973.
  9. Morton RW, Murphy KT, McKellar SR, et al. “A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength in healthy adults.” British Journal of Sports Medicine 2018;52(6):376–384.
  10. Tagawa R, Watanabe D, Ito K, et al. “Dose–response relationship between protein intake and muscle mass increase: a systematic review and meta-analysis of randomized controlled trials.” Nutrition Reviews 2021;79(1):66–75.
  11. Nunes EA, Colenso-Semple L, McKellar SR, et al. “Systematic review and meta-analysis of protein intake to support muscle mass and function in healthy adults.” Journal of Cachexia, Sarcopenia and Muscle 2022;13(2):795–810.
  12. Bandegan A, Courtney-Martin G, Rafii M, Pencharz PB, Lemon PWR. “Indicator Amino Acid–Derived Estimate of Dietary Protein Requirement for Male Bodybuilders on a Nontraining Day Is Several-Fold Greater than the Current Recommended Dietary Allowance.” Journal of Nutrition 2017;147(5):850–857.
  13. US Departments of Agriculture and Health and Human Services. Dietary Guidelines for Americans, 2025–2030. Published January 2026.
  14. Devries MC, Sithamparapillai A, Brimble KS, Banfield L, Morton RW, Phillips SM. “Changes in Kidney Function Do Not Differ between Healthy Adults Consuming Higher- Compared with Lower- or Normal-Protein Diets: A Systematic Review and Meta-Analysis.” Journal of Nutrition 2018;148(11):1760–1775.
  15. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. “KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.” Kidney International 2024;105(4S):S117–S314.
  16. Mathai JK, Liu Y, Stein HH. “Values for digestible indispensable amino acid scores (DIAAS) for some dairy and plant proteins may better describe protein quality than values calculated using the concept for protein digestibility-corrected amino acid scores (PDCAAS).” British Journal of Nutrition 2017;117(4):490–499.
  17. US Department of Agriculture, Agricultural Research Service. FoodData Central. fdc.nal.usda.gov.
  18. Res PT, Groen B, Pennings B, et al. “Protein ingestion before sleep improves postexercise overnight recovery.” Medicine & Science in Sports & Exercise 2012;44(8):1560–1569.
  19. Moore DR, Robinson MJ, Fry JL, et al. “Ingested protein dose response of muscle and albumin protein synthesis after resistance exercise in young men.” American Journal of Clinical Nutrition 2009;89(1):161–168.
  20. Macnaughton LS, Wardle SL, Witard OC, et al. “The response of muscle protein synthesis following whole-body resistance exercise is greater following 40 g than 20 g of ingested whey protein.” Physiological Reports 2016;4(15):e12893.
  21. Trommelen J, van Lieshout GAA, Nyakayiru J, et al. “The anabolic response to protein ingestion during recovery from exercise has no upper limit in magnitude and duration in vivo in humans.” Cell Reports Medicine 2023;4(12):101324.
  22. Mamerow MM, Mettler JA, English KL, et al. “Dietary Protein Distribution Positively Influences 24-h Muscle Protein Synthesis in Healthy Adults.” Journal of Nutrition 2014;144(6):876–880.
  23. Arnal MA, Mosoni L, Boirie Y, et al. “Protein pulse feeding improves protein retention in elderly women.” American Journal of Clinical Nutrition 1999;69(6):1202–1208.
  24. De Leon A, Roemmich JN, Casperson SL. “Daily Dietary Protein Distribution Does Not Influence Changes in Body Composition During Weight Loss in Women of Reproductive Years with Overweight or Obesity: A Randomized Controlled Trial.” Journal of Nutrition 2024;154(4):1347–1355.
  25. Layman DK, Anthony TG, Paddon-Jones D, et al. “Impacts of protein quantity and distribution on body composition.” Frontiers in Nutrition 2024;11:1388986.
  26. Cuthbertson D, Smith K, Babraj J, et al. “Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle.” FASEB Journal 2005;19(3):422–424.
  27. Katsanos CS, Kobayashi H, Sheffield-Moore M, Aarsland A, Wolfe RR. “A high proportion of leucine is required for optimal stimulation of the rate of muscle protein synthesis by essential amino acids in the elderly.” American Journal of Physiology: Endocrinology and Metabolism 2006;291(2):E381–E387.
  28. Bauer J, Biolo G, Cederholm T, et al. “Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group.” Journal of the American Medical Directors Association 2013;14(8):542–559.
  29. Young VR, Pellett PL. “Plant proteins in relation to human protein and amino acid nutrition.” American Journal of Clinical Nutrition 1994;59(5 Suppl):1203S–1212S.
  30. Pinckaers PJM, Kouw IWK, Hendriks FK, et al. “The muscle protein synthetic response to the ingestion of a plant-derived protein blend does not differ from an equivalent amount of milk protein in healthy, young males.” Journal of Nutrition 2022;152(12):2734–2743.
  31. Weigle DS, Breen PA, Matthys CC, et al. “A high-protein diet induces sustained reductions in appetite, ad libitum caloric intake, and body weight despite compensatory changes in diurnal plasma leptin and ghrelin concentrations.” American Journal of Clinical Nutrition 2005;82(1):41–48.
  32. Leidy HJ, Clifton PM, Astrup A, et al. “The role of protein in weight loss and maintenance.” American Journal of Clinical Nutrition 2015;101(6):1320S–1329S.
  33. Halton TL, Hu FB. “The effects of high protein diets on thermogenesis, satiety and weight loss: a critical review.” Journal of the American College of Nutrition 2004;23(5):373–385.
  34. Serhan CN, Levy BD. “Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators.” Journal of Clinical Investigation 2018;128(7):2657–2669.
  35. O’Donnell VB, Schebb NH, Milne GL, et al. “Failure to apply standard limit-of-detection or limit-of-quantitation criteria to specialized pro-resolving mediator analysis incorrectly characterizes their presence in biological samples.” Nature Communications 2023;14:7172.
  36. Burdge GC, Wootton SA. “Conversion of α-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women.” British Journal of Nutrition 2002;88(4):411–420.
  37. Burdge GC, Jones AE, Wootton SA. “Eicosapentaenoic and docosapentaenoic acids are the principal products of α-linolenic acid metabolism in young men.” British Journal of Nutrition 2002;88(4):355–363.
  38. Varre JV, Statham T, Smith AF, et al. Nutritional composition of beef: a comparison of commercial North American grass- and grain-finishing systems. Journal of Animal Science. 2026. doi:10.1093/jas/skaf436.
  39. Johnson GH, Fritsche K. “Effect of dietary linoleic acid on markers of inflammation in healthy persons: a systematic review of randomized controlled trials.” Journal of the Academy of Nutrition and Dietetics 2012;112(7):1029–1041.
  40. Rett BS, Whelan J. “Increasing dietary linoleic acid does not increase tissue arachidonic acid content in adults consuming Western-type diets: a systematic review.” Nutrition & Metabolism 2011;8:36.
  41. Marklund M, Wu JHY, Imamura F, et al. “Biomarkers of Dietary Omega-6 Fatty Acids and Incident Cardiovascular Disease and Mortality: An Individual-Level Pooled Analysis of 30 Cohort Studies.” Circulation 2019;139(21):2422–2436.
  42. Hooper L, Martin N, Jimoh OF, Kirk C, Foster E, Abdelhamid AS. “Reduction in saturated fat intake for cardiovascular disease.” Cochrane Database of Systematic Reviews 2020, Issue 5, CD011737.pub3.
  43. Sacks FM, Lichtenstein AH, Wu JHY, et al. “Dietary Fats and Cardiovascular Disease: A Presidential Advisory From the American Heart Association.” Circulation 2017;136(3):e1–e23.
  44. Dehghan M, Mente A, Zhang X, et al. “Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study.” The Lancet 2017;390(10107):2050–2062. (See also the critical correspondence in The Lancet 2017–2018.)
  45. Dietary Guidelines Advisory Committee. Scientific Report of the 2015 Dietary Guidelines Advisory Committee. US Departments of Agriculture and Health and Human Services, 2015.
  46. Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC. “Trans fatty acids and cardiovascular disease.” New England Journal of Medicine 2006;354(15):1601–1613.
  47. US Food and Drug Administration. “Final Determination Regarding Partially Hydrogenated Oils.” Federal Register, 17 June 2015; 80 FR 34650.
  48. De Alzaa F, Guillaume C, Ravetti L. “Evaluation of Chemical and Physical Changes in Different Commercial Oils during Heating.” Acta Scientific Nutritional Health 2018;2(6):2–11. (Conducted by a laboratory affiliated with the olive oil industry.)
  49. Guasch-Ferré M, Li Y, Willett WC, et al. “Consumption of Olive Oil and Risk of Total and Cause-Specific Mortality Among U.S. Adults.” Journal of the American College of Cardiology 2022;79(2):101–112.
  50. Jenkins DJ, Wolever TM, Taylor RH, et al. “Glycemic index of foods: a physiological basis for carbohydrate exchange.” American Journal of Clinical Nutrition 1981;34(3):362–366.
  51. Matthan NR, Ausman LM, Meng H, Tighiouart H, Lichtenstein AH. “Estimating the reliability of glycemic index values and potential sources of methodological and biological variability.” American Journal of Clinical Nutrition 2016;104(4):1004–1013.
  52. Vega-López S, Ausman LM, Griffith JL, Lichtenstein AH. “Interindividual variability and intra-individual reproducibility of glycemic index values for commercial white bread.” Diabetes Care 2007;30(6):1412–1417.
  53. Sacks FM, Carey VJ, Anderson CAM, et al. “Effects of high vs low glycemic index of dietary carbohydrate on cardiovascular disease risk factors and insulin sensitivity: the OmniCarb randomized clinical trial.” JAMA 2014;312(23):2531–2541.
  54. Zeevi D, Korem T, Zmora N, et al. “Personalized Nutrition by Prediction of Glycemic Responses.” Cell 2015;163(5):1079–1094. (Several authors have commercial interests in personalized nutrition testing.)
  55. Reynolds A, Mann J, Cummings J, Winter N, Mete E, Te Morenga L. “Carbohydrate quality and human health: a series of systematic reviews and meta-analyses.” The Lancet 2019;393(10170):434–445.
  56. Quagliani D, Felt-Gunderson P. “Closing America’s Fiber Intake Gap.” American Journal of Lifestyle Medicine 2017;11(1):80–85.
  57. Birt DF, Boylston T, Hendrich S, et al. “Resistant starch: promise for improving human health.” Advances in Nutrition 2013;4(6):587–601.
  58. Aune D, Keum N, Giovannucci E, et al. “Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality: systematic review and dose-response meta-analysis of prospective studies.” BMJ 2016;353:i2716.
  59. Aune D, Giovannucci E, Boffetta P, et al. “Fruit and vegetable intake and the risk of cardiovascular disease, total cancer and all-cause mortality: a systematic review and dose-response meta-analysis of prospective studies.” International Journal of Epidemiology 2017;46(3):1029–1056.
  60. Hall KD, Ayuketah A, Brychta R, et al. “Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake.” Cell Metabolism 2019;30(1):67–77.e3.
  61. Dicken SJ, Batterham RL, et al. Ultra-processed or minimally processed diets following healthy dietary guidelines on weight and cardiometabolic health: a randomised, crossover trial. Nature Medicine. 2025;31(10):3297–3308. doi:10.1038/s41591-025-03842-0. (See the two accompanying critiques published in Nature Medicine the same year.)
  62. Lane MM, Gamage E, Du S, et al. “Ultra-processed food exposure and adverse health outcomes: umbrella review of epidemiological meta-analyses.” BMJ 2024;384:e077310.
  63. Liang S, Zhou Y, Zhang Q, Yu S, Wu S. “Ultra-processed foods and risk of all-cause mortality: an updated systematic review and dose-response meta-analysis of prospective cohort studies.” Systematic Reviews 2025;14:53.
  64. Monteiro CA, Cannon G, Levy RB, et al. “Ultra-processed foods: what they are and how to identify them.” Public Health Nutrition 2019;22(5):936–941.
  65. Braesco V, Souchon I, Sauvant P, et al. “Ultra-processed foods: how functional is the NOVA system?” European Journal of Clinical Nutrition 2022;76:1245–1253.
  66. Gibney MJ. “Ultra-Processed Foods: Definitions and Policy Issues.” Current Developments in Nutrition 2019;3(2):nzy077.
  67. Mills S, Brown H, Wrieden W, White M, Adams J. “Frequency of eating home cooked meals and potential benefits for diet and health: cross-sectional analysis of a population-based cohort study.” International Journal of Behavioral Nutrition and Physical Activity 2017;14:109.
  68. Wolfson JA, Bleich SN. “Is cooking at home associated with better diet quality or weight-loss intention?” Public Health Nutrition 2015;18(8):1397–1406.
  69. Sender R, Fuchs S, Milo R. “Revised Estimates for the Number of Human and Bacteria Cells in the Body.” PLoS Biology 2016;14(8):e1002533.
  70. Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F. “From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites.” Cell 2016;165(6):1332–1345.
  71. David LA, Maurice CF, Carmody RN, et al. “Diet rapidly and reproducibly alters the human gut microbiome.” Nature 2014;505(7484):559–563.
  72. Rothschild D, Weissbrod O, Barkan E, et al. “Environment dominates over host genetics in shaping human gut microbiota.” Nature 2018;555(7695):210–215.
  73. Falony G, Joossens M, Vieira-Silva S, et al. “Population-level analysis of gut microbiome variation.” Science 2016;352(6285):560–564.
  74. Wastyk HC, Fragiadakis GK, Perelman D, et al. “Gut-microbiota-targeted diets modulate human immune status.” Cell 2021;184(16):4137–4153.
  75. McDonald D, Hyde E, Debelius JW, et al. “American Gut: an Open Platform for Citizen Science Microbiome Research.” mSystems 2018;3(3):e00031-18.
  76. McFarland LV, Evans CT, Goldstein EJC. “Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis.” Frontiers in Medicine 2018;5:124.
  77. Zmora N, Zilberman-Schapira G, Suez J, et al. “Personalized Gut Mucosal Colonization Resistance to Empiric Probiotics Is Associated with Unique Host and Microbiome Features.” Cell 2018;174(6):1388–1405.
  78. Suez J, Zmora N, Zilberman-Schapira G, et al. “Post-Antibiotic Gut Mucosal Microbiome Reconstitution Is Impaired by Probiotics and Improved by Autologous FMT.” Cell 2018;174(6):1406–1423.
  79. Hanage WP. “Microbiology: Microbiome science needs a healthy dose of scepticism.” Nature 2014;512(7514):247–248.
  80. Institute of Medicine (now the National Academies of Sciences, Engineering, and Medicine). Dietary Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulfate. National Academies Press, 2004.
  81. Cheuvront SN, Kenefick RW. “Dehydration: physiology, assessment, and performance effects.” Comprehensive Physiology 2014;4(1):257–285.
  82. Wittbrodt MT, Millard-Stafford M. “Dehydration Impairs Cognitive Performance: A Meta-analysis.” Medicine & Science in Sports & Exercise 2018;50(11):2360–2368.
  83. Almond CSD, Shin AY, Fortescue EB, et al. “Hyponatremia among runners in the Boston Marathon.” New England Journal of Medicine 2005;352(15):1550–1556.
  84. Perrier ET, Bottin JH, Vecchio M, Lemetais G. “Criterion values for urine-specific gravity and urine colour representing adequate water intake in healthy adults.” European Journal of Clinical Nutrition 2017;71(4):561–563.
  85. Killer SC, Blannin AK, Jeukendrup AE. “No Evidence of Dehydration with Moderate Daily Coffee Intake: A Counterbalanced Cross-Over Study in a Free-Living Population.” PLoS One 2014;9(1):e84154.
  86. Loftfield E, Cornelis MC, Caporaso N, Yu K, Sinha R, Freedman N. “Association of Coffee Drinking With Mortality by Genetic Variation in Caffeine Metabolism: Findings From the UK Biobank.” JAMA Internal Medicine 2018;178(8):1086–1097.
  87. Gunter MJ, Murphy N, Cross AJ, et al. “Coffee Drinking and Mortality in 10 European Countries: A Multinational Cohort Study.” Annals of Internal Medicine 2017;167(4):236–247.
  88. Inoue-Choi M, Ramirez Y, Cornelis MC, Berrington de González A, Freedman ND, Loftfield E. “Tea Consumption and All-Cause and Cause-Specific Mortality in the UK Biobank.” Annals of Internal Medicine 2022;175(9):1201–1211.
  89. EFSA Panel on Dietetic Products, Nutrition and Allergies. “Scientific Opinion on the safety of caffeine.” EFSA Journal 2015;13(5):4102.
  90. Zhao J, Stockwell T, Naimi T, Churchill S, Clay J, Sherk A. “Association Between Daily Alcohol Intake and Risk of All-Cause Mortality: A Systematic Review and Meta-analyses.” JAMA Network Open 2023;6(3):e236185.
  91. Office of the US Surgeon General. Alcohol and Cancer Risk: The U.S. Surgeon General’s Advisory. January 2025.
  92. World Health Organization Regional Office for Europe. “No level of alcohol consumption is safe for our health.” Statement, 4 January 2023.
  93. Greyling A, Appleton KM, Raben A, Mela DJ. “Acute glycemic and insulinemic effects of low-energy sweeteners: a systematic review and meta-analysis of randomized controlled trials.” American Journal of Clinical Nutrition 2020;112(4):1002–1014. (Two authors report food industry affiliations.)
  94. World Health Organization. Use of non-sugar sweeteners: WHO guideline. 15 May 2023.
  95. Suez J, Cohen Y, Valdés-Mas R, et al. “Personalized microbiome-driven effects of non-nutritive sweeteners on human glucose tolerance.” Cell 2022;185(18):3307–3328. (See also Suez J, et al., Nature 2014;514:181–186, which was predominantly a mouse study with a seven-participant human arm.)
  96. International Agency for Research on Cancer and the Joint FAO/WHO Expert Committee on Food Additives. “Aspartame hazard and risk assessment results released.” 14 July 2023.
  97. Witkowski M, Nemet I, Alamri H, et al. “The artificial sweetener erythritol and cardiovascular event risk.” Nature Medicine 2023;29:710–718. (See also the FDA’s formal evaluation of this article.)
  98. Westerterp KR. “Diet induced thermogenesis.” Nutrition & Metabolism 2004;1:5.
  99. Bellisle F, McDevitt R, Prentice AM. “Meal frequency and energy balance.” British Journal of Nutrition 1997;77(Suppl 1):S57–S70.
  100. Munsters MJM, Saris WHM. “Effects of meal frequency on metabolic profiles and substrate partitioning in lean healthy males.” PLoS ONE 2012;7(6):e38632.
  101. Cameron JD, Cyr MJ, Doucet É. “Increased meal frequency does not promote greater weight loss in subjects who were prescribed an 8-week equi-energetic energy-restricted diet.” British Journal of Nutrition 2010;103(8):1098–1101.
  102. Farshchi HR, Taylor MA, Macdonald IA. “Decreased thermic effect of food after an irregular compared with a regular meal pattern in healthy lean women.” International Journal of Obesity 2004;28(5):653–660.
  103. Sievert K, Hussain SM, Page MJ, et al. “Effect of breakfast on weight and energy intake: systematic review and meta-analysis of randomised controlled trials.” BMJ 2019;364:l42.
  104. Betts JA, Richardson JD, Chowdhury EA, Holman GD, Tsintzas K, Thompson D. “The causal role of breakfast in energy balance and health: a randomized controlled trial in lean adults.” American Journal of Clinical Nutrition 2014;100(2):539–547.
  105. Lowe DA, Wu N, Rohdin-Bibby L, et al. “Effects of Time-Restricted Eating on Weight Loss and Other Metabolic Parameters in Women and Men With Overweight and Obesity: The TREAT Randomized Clinical Trial.” JAMA Internal Medicine 2020;180(11):1491–1499.
  106. Liu D, Huang Y, Huang C, et al. “Calorie Restriction with or without Time-Restricted Eating in Weight Loss.” New England Journal of Medicine 2022;386(16):1495–1504.
  107. Jamshed H, Steger FL, Bryan DR, et al. “Effectiveness of Early Time-Restricted Eating for Weight Loss, Fat Loss, and Cardiometabolic Health in Adults With Obesity: A Randomized Clinical Trial.” JAMA Internal Medicine 2022;182(9):953–962.
  108. Schimenes BC, Alvarenga TA, Tufik SB, Tufik S, Andersen ML. Time-restricted eating and metabolic health: implications for nutritional strategies and weight loss. Frontiers in Nutrition. 2026;13:1872454. doi:10.3389/fnut.2026.1872454.
  109. Hollands GJ, Shemilt I, Marteau TM, et al. “Portion, package or tableware size for changing selection and consumption of food, alcohol and tobacco.” Cochrane Database of Systematic Reviews 2015, Issue 9, CD011045.
  110. Wing RR, Phelan S. “Long-term weight loss maintenance.” American Journal of Clinical Nutrition 2005;82(1 Suppl):222S–225S.
Part Four Movement (Essential 2) 60
  1. Mandsager K, Harb S, Cremer P, Phelan D, Nissen SE, Jaber W. Association of Cardiorespiratory Fitness With Long-term Mortality Among Adults Undergoing Exercise Treadmill Testing. JAMA Network Open. 2018;1(6):e183605.
  2. Leong DP, Teo KK, Rangarajan S, et al. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. The Lancet. 2015;386(9990):266–273.
  3. Newman AB, Kupelian V, Visser M, et al. Strength, but not muscle mass, is associated with mortality in the Health, Aging and Body Composition Study cohort. Journals of Gerontology Series A. 2006;61(1):72–77.
  4. Li R, Xia J, Zhang X, et al. Associations of Muscle Mass and Strength with All-Cause Mortality among US Older Adults. Medicine & Science in Sports & Exercise. 2018;50(3):458–467.
  5. Mitchell WK, Williams J, Atherton P, Larvin M, Lund J, Narici M. Sarcopenia, Dynapenia, and the Impact of Advancing Age on Human Skeletal Muscle Size and Strength: A Quantitative Review. Frontiers in Physiology. 2012;3:260.
  6. Momma H, Kawakami R, Honda T, Sawada SS. Muscle-strengthening activities are associated with lower risk and mortality in major non-communicable diseases: a systematic review and meta-analysis of cohort studies. British Journal of Sports Medicine. 2022;56(13):755–763.
  7. Noetel M, Sanders T, Gallardo-Gómez D, et al. Effect of exercise for depression: systematic review and network meta-analysis of randomised controlled trials. BMJ. 2024;384:e075847.
  8. Han H, Zhang J, Zhang F, Li F, Wu Z. Optimal exercise interventions for enhancing cognitive function in older adults: a network meta-analysis. Frontiers in Aging Neuroscience. 2025;17:1510773.
  9. US Department of Health and Human Services. Physical Activity Guidelines for Americans, 2nd edition. Washington, DC: US DHHS; 2018.
  10. Bull FC, Al-Ansari SS, Biddle S, et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. British Journal of Sports Medicine. 2020;54(24):1451–1462.
  11. Seiler S, Kjerland GØ. Quantifying training intensity distribution in elite endurance athletes: is there evidence for an “optimal” distribution? Scandinavian Journal of Medicine & Science in Sports. 2006;16(1):49–56.
  12. Maunder E, Plews DJ, Kilding AE. Contextualising Maximal Fat Oxidation During Exercise: Determinants and Normative Values. Frontiers in Physiology. 2018;9:599.
  13. Schoenfeld BJ, Aragon AA, Wilborn CD, Krieger JW, Sonmez GT. Body composition changes associated with fasted versus non-fasted aerobic exercise. Journal of the International Society of Sports Nutrition. 2014;11:54.
  14. Schoenfeld BJ, Ogborn D, Krieger JW. Effects of Resistance Training Frequency on Measures of Muscle Hypertrophy: A Systematic Review and Meta-Analysis. Sports Medicine. 2016;46(11):1689–1697.
  15. Schoenfeld BJ, Grgic J, Krieger J. How many times per week should a muscle be trained to maximize muscle hypertrophy? A systematic review and meta-analysis of studies examining the effects of resistance training frequency. Journal of Sports Sciences. 2019;37(11):1286–1295.
  16. Pelland JC, Remmert JF, Robinson ZP, Hinson SR, Zourdos MC. The Resistance Training Dose Response: Meta-Regressions Exploring the Effects of Weekly Volume and Frequency on Muscle Hypertrophy and Strength Gains. Sports Medicine. 2026;56(2):481–505. doi:10.1007/s40279-025-02344-w.
  17. Schoenfeld BJ, Ogborn D, Krieger JW. Dose-response relationship between weekly resistance training volume and increases in muscle mass: A systematic review and meta-analysis. Journal of Sports Sciences. 2017;35(11):1073–1082.
  18. Schoenfeld BJ, Grgic J, Ogborn D, Krieger JW. Strength and Hypertrophy Adaptations Between Low- vs. High-Load Resistance Training: A Systematic Review and Meta-analysis. Journal of Strength and Conditioning Research. 2017;31(12):3508–3523.
  19. Currier BS, D’Souza AC, Fiatarone Singh MA, … Phillips SM; American College of Sports Medicine. Position Stand: Resistance Training Prescription for Muscle Function, Hypertrophy, and Physical Performance in Healthy Adults: An Overview of Reviews. Medicine & Science in Sports & Exercise. 2026;58(4):851–872.
  20. Refalo MC, Helms ER, Trexler ET, Hamilton DL, Fyfe JJ. Influence of Resistance Training Proximity-to-Failure on Skeletal Muscle Hypertrophy: A Systematic Review with Meta-analysis. Sports Medicine. 2023;53:649–665.
  21. Robinson ZP, Pelland JC, Remmert JF, Refalo MC, Jukic I, Steele J, Zourdos MC. Exploring the Dose–Response Relationship Between Estimated Resistance Training Proximity to Failure, Strength Gain, and Muscle Hypertrophy. Sports Medicine. 2024;54:2209–2231.
  22. Fiatarone MA, Marks EC, Ryan ND, Meredith CN, Lipsitz LA, Evans WJ. High-intensity strength training in nonagenarians: effects on skeletal muscle. JAMA. 1990;263(22):3029–3034.
  23. Roberts BM, Nuckols G, Krieger JW. Sex Differences in Resistance Training: A Systematic Review and Meta-Analysis. Journal of Strength and Conditioning Research. 2020;34(5):1448–1460.
  24. Paluch AE, Bajpai S, Bassett DR, et al. Daily steps and all-cause mortality: a meta-analysis of 15 international cohorts. The Lancet Public Health. 2022;7(3):e219–e228.
  25. Ding D, Nguyen B, Nau T, et al. Daily steps and health outcomes in adults: a systematic review and dose–response meta-analysis. The Lancet Public Health. 2025;10(8):e668–e681.
  26. Tudor-Locke C, Bassett DR. How many steps/day are enough? Preliminary pedometer indices for public health. Sports Medicine. 2004;34(1):1–8.
  27. Ekelund U, Steene-Johannessen J, Brown WJ, et al. Does physical activity attenuate, or even eliminate, the detrimental association of sitting time with mortality? A harmonised meta-analysis of data from more than 1 million men and women. The Lancet. 2016;388(10051):1302–1310.
  28. Dunstan DW, Kingwell BA, Larsen R, et al. Breaking up prolonged sitting reduces postprandial glucose and insulin responses. Diabetes Care. 2012;35(5):976–983.
  29. Gale J, Martin H, Haszard J, Peddie M. The acute effects of interrupting prolonged sitting with regular activity breaks on postprandial glucose and insulin in adults: a systematic review and meta-analysis. Obesity Reviews. 2026:e70152. doi:10.1111/obr.70152.
  30. Stamatakis E, Ahmadi MN, Gill JMR, et al. Association of wearable device-measured vigorous intermittent lifestyle physical activity with mortality. Nature Medicine. 2022;28:2521–2529.
  31. Behm DG, Blazevich AJ, Kay AD, McHugh M. Acute effects of muscle stretching on physical performance, range of motion, and injury incidence in healthy active individuals: a systematic review. Applied Physiology, Nutrition, and Metabolism. 2016;41(1):1–11.
  32. Esteban-García P, et al. Does the Inclusion of Static or Dynamic Stretching in the Warm-Up Routine Improve Jump Height and ROM in Physically Active Individuals? A Systematic Review and Meta-Analysis. Applied Sciences. 2024;14(9):3872.
  33. Lauersen JB, Bertelsen DM, Andersen LB. The effectiveness of exercise interventions to prevent sports injuries: a systematic review and meta-analysis of randomised controlled trials. British Journal of Sports Medicine. 2014;48(11):871–877.
  34. Lauersen JB, Andersen TE, Andersen LB. Strength training as superior, dose-dependent and safe prevention of acute and overuse sports injuries: a systematic review, qualitative analysis and meta-analysis. British Journal of Sports Medicine. 2018;52(24):1557–1563.
  35. Afonso J, Ramirez-Campillo R, Moscão J, et al. Strength Training versus Stretching for Improving Range of Motion: A Systematic Review and Meta-Analysis. Healthcare. 2021;9(4):427.
  36. Jeffreys I. Warm-up revisited: the RAMP method of optimising performance preparation. UKSCA Journal. 2006;6:15–19.
  37. Dupuy O, Douzi W, Theurot D, Bosquet L, Dugué B. An Evidence-Based Approach for Choosing Post-exercise Recovery Techniques to Reduce Markers of Muscle Damage, Soreness, Fatigue, and Inflammation: A Systematic Review With Meta-Analysis. Frontiers in Physiology. 2018;9:403.
  38. Konrad A, Glashüttner C, Reiner MM, Bernsteiner D, Tilp M. The Acute Effects of a Percussive Massage Treatment with a Hypervolt Device on Plantar Flexor Muscles’ Range of Motion and Performance. Journal of Sports Science and Medicine. 2020;19(4):690–694.
  39. Brown F, Gissane C, Howatson G, van Someren K, Pedlar C, Hill J. Compression Garments and Recovery from Exercise: A Meta-Analysis. Sports Medicine. 2017;47(11):2245–2267.
  40. Roberts LA, Raastad T, Markworth JF, et al. Post-exercise cold water immersion attenuates acute anabolic signalling and long-term adaptations in muscle to strength training. The Journal of Physiology. 2015;593(18):4285–4301.
  41. Bell L, Ruddock A, Maden-Wilkinson T, Rogerson D. Overreaching and overtraining in strength sports and resistance training: A scoping review. Journal of Sports Sciences. 2020;38(16):1897–1912.
  42. Meeusen R, Duclos M, Foster C, et al. Prevention, diagnosis and treatment of the overtraining syndrome: joint consensus statement of the European College of Sport Science and the American College of Sports Medicine. European Journal of Sport Science. 2013;13(1):1–24.
  43. Buchheit M. Monitoring training status with HR measures: do all roads lead to Rome? Frontiers in Physiology. 2014;5:73.
  44. Kaminsky LA, Arena R, Myers J. Reference Standards for Cardiorespiratory Fitness Measured With Cardiopulmonary Exercise Testing: Data From the Fitness Registry and the Importance of Exercise National Database (FRIEND). Mayo Clinic Proceedings. 2015;90(11):1515–1523.
  45. Steffl M, Chrudimsky J, Tufano JJ, et al. Grip strength values and cut-off points based on over 200,000 adults of the German National Cohort: a comparison to the EWGSOP2 cut-off points. Age and Ageing. 2023;52(1):afac324.
  46. Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis (EWGSOP2). Age and Ageing. 2019;48(1):16–31.
  47. Mayorga-Vega D, Bocanegra-Parrilla R, Ornelas M, Viciana J. Criterion-Related Validity of the Distance- and Time-Based Walk/Run Field Tests for Estimating Cardiorespiratory Fitness: A Systematic Review and Meta-Analysis. PLOS ONE. 2016;11(3):e0151671.
  48. Molina-Garcia P, Notbohm HL, Schumann M, et al. Validity of Estimating the Maximal Oxygen Consumption by Consumer Wearables: A Systematic Review with Meta-analysis and Expert Statement of the INTERLIVE Network. Sports Medicine. 2022;52(7):1577–1597.
  49. Fox SM, Naughton JP, Haskell WL. Physical activity and the prevention of coronary heart disease. Annals of Clinical Research. 1971;3(6):404–432.
  50. Tanaka H, Monahan KD, Seals DR. Age-predicted maximal heart rate revisited. Journal of the American College of Cardiology. 2001;37(1):153–156.
  51. Gulati M, Shaw LJ, Thisted RA, Black HR, Bairey Merz CN, Arnsdorf MF. Heart rate response to exercise stress testing in asymptomatic women: the St. James Women Take Heart Project. Circulation. 2010;122(2):130–137.
  52. Storoschuk KL, et al. Much Ado About Zone 2: A Narrative Review Assessing the Efficacy of Zone 2 Training for Improving Mitochondrial Capacity and Cardiorespiratory Fitness in the General Population. Sports Medicine. 2025. doi:10.1007/s40279-025-02261-y.
  53. Granata C, Jamnick NA, Bishop DJ. Training-Induced Changes in Mitochondrial Content and Respiratory Function in Human Skeletal Muscle. Sports Medicine. 2018;48:1809–1828.
  54. MacInnis MJ, Gibala MJ. Physiological adaptations to interval training and the role of exercise intensity. The Journal of Physiology. 2017;595(9):2915–2930.
  55. Aird TP, Davies RW, Carson BP. Effects of fasted vs fed-state exercise on performance and post-exercise metabolism: A systematic review and meta-analysis. Scandinavian Journal of Medicine & Science in Sports. 2018;28(5):1476–1493.
  56. Seiler S. What is best practice for training intensity and duration distribution in endurance athletes? International Journal of Sports Physiology and Performance. 2010;5(3):276–291.
  57. Rosenblat MA, Perrotta AS, Vicenzino B. Polarized vs. Threshold Training Intensity Distribution on Endurance Sport Performance: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of Strength and Conditioning Research. 2019;33(12):3491–3500.
  58. Helgerud J, Høydal K, Wang E, et al. Aerobic high-intensity intervals improve VO2max more than moderate training. Medicine & Science in Sports & Exercise. 2007;39(4):665–671.
  59. Gibala MJ, Little JP, van Essen M, et al. Short-term sprint interval versus traditional endurance training: similar initial adaptations in human skeletal muscle and exercise performance. The Journal of Physiology. 2006;575(3):901–911.
  60. Milanović Z, Sporiš G, Weston M. Effectiveness of High-Intensity Interval Training and Continuous Endurance Training for VO2max Improvements: A Systematic Review and Meta-Analysis of Controlled Trials. Sports Medicine. 2015;45(10):1469–1481.
Part Five Sleep (Essential 3) 28
  1. Watson NF, Badr MS, Belenky G, et al. Recommended amount of sleep for a healthy adult: a joint consensus statement of the American Academy of Sleep Medicine and Sleep Research Society. J Clin Sleep Med. 2015;11(6):591–592.
  2. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999;354(9188):1435–1439.
  3. Broussard JL, Ehrmann DA, Van Cauter E, Tasali E, Brady MJ. Impaired insulin signaling in human adipocytes after experimental sleep restriction: a randomized, crossover study. Ann Intern Med. 2012;157(8):549–557.
  4. Nedeltcheva AV, Kilkus JM, Imperial J, Schoeller DA, Penev PD. Insufficient sleep undermines dietary efforts to reduce adiposity. Ann Intern Med. 2010;153(7):435–441.
  5. Wang X, Sparks JR, Bowyer KP, Youngstedt SD. Influence of sleep restriction on weight loss outcomes associated with caloric restriction. Sleep. 2018;41(5):zsy027.
  6. Gresser D, McLimans K, Lee S, Morgan-Bathke M. The impact of sleep deprivation on hunger-related hormones: a meta-analysis and systematic review. Obesities. 2025;5(2):48.
  7. Cappuccio FP, D’Elia L, Strazzullo P, Miller MA. Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. Sleep. 2010;33(5):585–592.
  8. García-Perdomo HA, Zapata-Copete J, Rojas-Cerón CA. Sleep duration and risk of all-cause mortality: a systematic review and meta-analysis. Epidemiol Psychiatr Sci. 2019;28(6):578–588.
  9. Leproult R, Van Cauter E. Effect of 1 week of sleep restriction on testosterone levels in young healthy men. JAMA. 2011;305(21):2173–2174.
  10. Mah CD, Mah KE, Kezirian EJ, Dement WC. The effects of sleep extension on the athletic performance of collegiate basketball players. Sleep. 2011;34(7):943–950.
  11. Milewski MD, Skaggs DL, Bishop GA, et al. Chronic lack of sleep is associated with increased sports injuries in adolescent athletes. J Pediatr Orthop. 2014;34(2):129–133.
  12. Van Dongen HPA, Maislin G, Mullington JM, Dinges DF. The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep. 2003;26(2):117–126.
  13. Edinger JD, Arnedt JT, Bertisch SM, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2021;17(2):255–262.
  14. Brown TM, Brainard GC, Cajochen C, et al. Recommendations for daytime, evening, and nighttime indoor light exposure to best support physiology, sleep, and wakefulness in healthy adults. PLOS Biol. 2022;20(3):e3001571.
  15. Drake C, Roehrs T, Shambroom J, Roth T. Caffeine effects on sleep taken 0, 3, or 6 hours before going to bed. J Clin Sleep Med. 2013;9(11):1195–1200.
  16. Nehlig A. Interindividual differences in caffeine metabolism and factors driving caffeine consumption. Pharmacol Rev. 2018;70(2):384–411.
  17. Gardiner C, Weakley J, Burke LM, et al. The effect of alcohol on subsequent sleep in healthy adults: a systematic review and meta-analysis. Sleep Med Rev. 2025;80:102030.
  18. Baniassadi A, Manor B, Yu W, Travison T, Lipsitz L. Nighttime ambient temperature and sleep in community-dwelling older adults. Sci Total Environ. 2023:165623. doi:10.1016/j.scitotenv.2023.165623.
  19. Lopez-Minguez J, Saxena R, Bandín C, Scheer FAJL, Garaulet M. Interplay of dinner timing and MTNR1B type 2 diabetes risk variant on glucose tolerance and insulin secretion: a randomized crossover trial. Diabetes Care. 2022;45(3):512–519.
  20. Luna-Rangel FA, et al. Efficacy of blue-light blocking glasses on actigraphic sleep outcomes: a systematic review and meta-analysis of randomized controlled crossover trials. Front Neurol. 2025;16:1699303.
  21. Windred DP, Burns AC, Lane JM, et al. Sleep regularity is a stronger predictor of mortality risk than sleep duration: a prospective cohort study. Sleep. 2024;47(1):zsad253.
  22. Brooks A, Lack L. A brief afternoon nap following nocturnal sleep restriction: which nap duration is most recuperative? Sleep. 2006;29(6):831–840.
  23. Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016;165(2):125–133. doi:10.7326/M15-2175.
  24. Buysse DJ, Arnedt JT, Buenaver L, et al. Combination treatment for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. Published online April 13, 2026.
  25. Eastman CI, Burgess HJ. How to travel the world without jet lag. Sleep Med Clin. 2009;4(2):241–255.
  26. Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017;13(2):307–349.
  27. Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013;177(9):1006–1014.
  28. Kapur VK, Auckley DH, Chowdhuri S, et al. Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017;13(3):479–504.
Part Six Recovery (Essential 4) 26
  1. Segerstrom SC, Miller GE. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol Bull. 2004;130(4):601–630.
  2. Thau L, Gandhi J, Sharma S. Physiology, cortisol. In: StatPearls. Treasure Island, FL: StatPearls Publishing; NCBI Bookshelf NBK538239.
  3. Christakoudi S, Asimakopoulos A-G, Riboli E, Tsilidis KK. Links between the genetic determinants of morning plasma cortisol and body shape: a two-sample Mendelian randomisation study. Sci Rep. 2024;14:3230.
  4. Cadegiani FA, Kater CE. Adrenal fatigue does not exist: a systematic review. BMC Endocr Disord. 2016;16:48. (Erratum: BMC Endocr Disord. 2016;16:63.)
  5. Endocrine Society. Adrenal Fatigue. Endocrine Library. endocrine.org.
  6. Adam TC, Epel ES. Stress, eating and the reward system. Physiol Behav. 2007;91(4):449–458.
  7. Kim EJ, Dimsdale JE. The effect of psychosocial stress on sleep: a review of polysomnographic evidence. Behav Sleep Med. 2007;5(4):256–278.
  8. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999;354(9188):1435–1439.
  9. Singh B, Olds T, Curtis R, et al. Effectiveness of physical activity interventions for improving depression, anxiety and distress: an overview of systematic reviews. Br J Sports Med. 2023;57(18):1203–1209.
  10. Kredlow MA, Capozzoli MC, Hearon BA, Calkins AW, Otto MW. The effects of physical activity on sleep: a meta-analytic review. J Behav Med. 2015;38(3):427–449.
  11. White MP, Alcock I, Grellier J, et al. Spending at least 120 minutes a week in nature is associated with good health and wellbeing. Sci Rep. 2019;9:7730.
  12. Twohig-Bennett C, Jones A. The health benefits of the great outdoors: a systematic review and meta-analysis of greenspace exposure and health outcomes. Environ Res. 2018;166:628–637.
  13. Balban MY, Neri E, Kogon MM, Zeitzer JM, Spiegel D, Huberman AD. Brief structured respiration practices enhance mood and reduce physiological arousal. Cell Rep Med. 2023;4(1):100895.
  14. Shaffer F, Ginsberg JP. An overview of heart rate variability metrics and norms. Front Public Health. 2017;5:258.
  15. Goyal M, Singh S, Sibinga EMS, et al. Meditation programs for psychological stress and well-being: a systematic review and meta-analysis. JAMA Internal Medicine. 2014;174(3):357–368.
  16. Laukkanen JA, Laukkanen T, Kunutsor SK. Cardiovascular and other health benefits of sauna bathing: a review of the evidence. Mayo Clinic Proceedings. 2018;93(8):1111–1121.
  17. Laukkanen T, Khan H, Zaccardi F, Laukkanen JA. Association between sauna bathing and fatal cardiovascular and all-cause mortality events. JAMA Internal Medicine. 2015;175(4):542–548.
  18. Kunutsor SK, Jae SY, Laukkanen JA. Frequent sauna bathing offsets the increased risk of death due to low socioeconomic status: a prospective cohort study of middle-aged and older men. Experimental Gerontology. 2022;167:111906.
  19. Epstein Y, Shoenfeld Y. The link between sauna bathing and mortality may be noncausal. JAMA Internal Medicine. 2015;175(10):1718–1719.
  20. Engström Å, Hägglund H, Lee E, Wennberg M, Söderberg S, Andersson M. Sauna bathing in northern Sweden: results from the MONICA study 2022. International Journal of Circumpolar Health. 2024;83(1):2419698.
  21. Pizzey FK, Smith EC, Ruediger SL, Keating SE, Askew CD, Coombes JS, Bailey TG. The effect of heat therapy on blood pressure and peripheral vascular function: a systematic review and meta-analysis. Experimental Physiology. 2021;106(6):1317–1334.
  22. Atencio JK, Reed EL, Wiedenfeld Needham K, et al. Comparison of thermoregulatory, cardiovascular, and immune responses to different passive heat therapy modalities. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology. 2025;329(1):R20–R35.
  23. Kenttämies A, Karkola K. Death in sauna. Journal of Forensic Sciences. 2008;53(3):724–729.
  24. Garolla A, Torino M, Sartini B, et al. Seminal and molecular evidence that sauna exposure affects human spermatogenesis. Human Reproduction. 2013;28(4):877–885.
  25. Moretti ME, Bar-Oz B, Fried S, Koren G. Maternal hyperthermia and the risk for neural tube defects in offspring: systematic review and meta-analysis. Epidemiology. 2005;16(2):216–219.
  26. Raichle ME. The brain’s default mode network. Annu Rev Neurosci. 2015;38:433–447.
Part Seven Connection (Essential 5) 17
  1. Holt-Lunstad J, Smith TB, Baker M, Harris T, Stephenson D. Loneliness and social isolation as risk factors for mortality: a meta-analytic review. Perspect Psychol Sci. 2015;10(2):227–237.
  2. Holt-Lunstad J, Smith TB, Layton JB. Social relationships and mortality risk: a meta-analytic review. PLoS Med. 2010;7(7):e1000316.
  3. Office of the U.S. Surgeon General. Our Epidemic of Loneliness and Isolation: The U.S. Surgeon General’s Advisory on the Healing Effects of Social Connection and Community. U.S. Department of Health and Human Services; 2023.
  4. Berkman LF, Syme SL. Social networks, host resistance, and mortality: a nine-year follow-up study of Alameda County residents. Am J Epidemiol. 1979;109(2):186–204.
  5. Hughes ME, Waite LJ, Hawkley LC, Cacioppo JT. A short scale for measuring loneliness in large surveys: results from two population-based studies. Res Aging. 2004;26(6):655–672.
  6. Hall JA. How many hours does it take to make a friend? J Soc Pers Relat. 2019;36(4):1278–1296.
  7. Cruwys T, Dingle GA, Haslam C, Haslam SA, Jetten J, Morton TA. Social group memberships protect against future depression, alleviate depression symptoms and prevent depression relapse. Soc Sci Med. 2013;98:179–186.
  8. Haslam C, Cruwys T, Haslam SA, Dingle G, Chang MX. Groups 4 Health: evidence that a social-identity intervention that builds and strengthens social group membership improves mental health. J Affect Disord. 2016;194:188–195.
  9. Haslam C, Cruwys T, Chang MX, et al. GROUPS 4 HEALTH reduces loneliness and social anxiety in adults with psychological distress: findings from a randomized controlled trial. J Consult Clin Psychol. 2019;87(9):787–801.
  10. Okun MA, Yeung EW, Brown S. Volunteering by older adults and risk of mortality: a meta-analysis. Psychol Aging. 2013;28(2):564–577.
  11. Jenkinson CE, Dickens AP, Jones K, et al. Is volunteering a public health intervention? A systematic review and meta-analysis of the health and survival of volunteers. BMC Public Health. 2013;13:773.
  12. Masi CM, Chen HY, Hawkley LC, Cacioppo JT. A meta-analysis of interventions to reduce loneliness. Pers Soc Psychol Rev. 2011;15(3):219–266.
  13. Shor E, Roelfs DJ, Curreli M, Clemow L, Burg MM, Schwartz JE. Widowhood and mortality: a meta-analysis and meta-regression. Demography. 2012;49(2):575–606.
  14. Shukla A, Harper M, Pedersen E, et al. Hearing loss, loneliness, and social isolation: a systematic review. Otolaryngol Head Neck Surg. 2020;162(5):622–633.
  15. Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396(10248):413–446.
  16. Livingston G, Huntley J, Liu KY, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet. 2024;404(10452):572–628.
  17. Lin FR, Pike JR, Albert MS, et al. Hearing intervention versus health education control to reduce cognitive decline in older adults with hearing loss in the USA (ACHIEVE): a multicentre, randomised controlled trial. Lancet. 2023;402(10404):786–797.
Part Eight Supplements, the Last Five Percent 65
  1. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. New England Journal of Medicine. 1994;330(15):1029–1035.
  2. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. New England Journal of Medicine. 1996;334(18):1150–1155.
  3. Goodman GE, Thornquist MD, Balmes J, et al. The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping β-carotene and retinol supplements. Journal of the National Cancer Institute. 2004;96(23):1743–1750.
  4. Klein EA, Thompson IM, Tangen CM, et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2011;306(14):1549–1556.
  5. Kristal AR, Darke AK, Morris JS, et al. Baseline selenium status and effects of selenium and vitamin E supplementation on prostate cancer risk. Journal of the National Cancer Institute. 2014;106(3):djt456.
  6. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database of Systematic Reviews. 2012;(3):CD007176.
  7. Ristow M, Zarse K, Oberbach A, et al. Antioxidants prevent health-promoting effects of physical exercise in humans. Proceedings of the National Academy of Sciences. 2009;106(21):8665–8670.
  8. Paulsen G, Cumming KT, Holden G, et al. Vitamin C and E supplementation hampers cellular adaptation to endurance training in humans: a double-blind, randomised, controlled trial. The Journal of Physiology. 2014;592(8):1887–1901.
  9. Paulsen G, Hamarsland H, Cumming KT, et al. Vitamin C and E supplementation alters protein signalling after a strength training session, but not muscle growth during 10 weeks of training. The Journal of Physiology. 2014;592(24):5391–5408.
  10. US Preventive Services Task Force. Vitamin, mineral, and multivitamin supplementation to prevent cardiovascular disease and cancer: US Preventive Services Task Force recommendation statement. JAMA. 2022;327(23):2326–2333.
  11. The Age-Related Eye Disease Study 2 (AREDS2) Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the AREDS2 randomized clinical trial. JAMA. 2013;309(19):2005–2015.
  12. Kreider RB, Kalman DS, Antonio J, et al. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. Journal of the International Society of Sports Nutrition. 2017;14:18.
  13. EFSA Panel on Dietetic Products, Nutrition and Allergies. Creatine in combination with resistance training and improvement in muscle strength: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journal. 2016;14(2):4400.
  14. Antonio J, Candow DG, Forbes SC, et al. Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show? Journal of the International Society of Sports Nutrition. 2021;18:13.
  15. Xu C, Bi S, Zhang W, Luo L. The effects of creatine supplementation on cognitive function in adults: a systematic review and meta-analysis. Frontiers in Nutrition. 2024;11:1424972.
  16. McMorris T, Hale BJ, Pine BS, Williams TB. Creatine supplementation research fails to support the theoretical basis for an effect on cognition: evidence from a systematic review. Behavioural Brain Research. 2024;466:114982.
  17. National Institutes of Health, Office of Dietary Supplements. Magnesium: fact sheet for health professionals. Accessed October 2026.
  18. Linus Pauling Institute Micronutrient Information Center. Micronutrient inadequacies in the US population: an overview (NHANES 2007–2010); and Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington, DC: National Academy Press; 1998.
  19. Schuster J, Cycelskij I, Lopresti A, Hahn A. Magnesium Bisglycinate Supplementation in Healthy Adults Reporting Poor Sleep: A Randomized, Placebo-Controlled Trial. Nature and Science of Sleep. 2025;17:2027–2040. doi:10.2147/NSS.S524348.
  20. Yamadera W, Inagawa K, Chiba S, Bannai M, Takahashi M, Nakayama K. Glycine ingestion improves subjective sleep quality in human volunteers, correlating with polysomnographic changes. Sleep and Biological Rhythms. 2007;5(2):126–131. See also Bannai M, Kawai N, Ono K, Nakahara K, Murakami N. The effects of glycine on subjective daytime performance in partially sleep-restricted healthy volunteers. Frontiers in Neurology. 2012;3:61; and Inagawa K, Hiraoka T, Kohda T, Yamadera W, Takahashi M. Subjective effects of glycine ingestion before bedtime on sleep quality. Sleep and Biological Rhythms. 2006;4(1):75–77. Disclosure: several authors of these papers were employed by Ajinomoto Co., Inc., a manufacturer of amino acids.
  21. Soh J, Raventhiran S, Lee JH, et al. The effect of glycine administration on the characteristics of physiological systems in human adults: a systematic review. GeroScience. 2024;46(1):219–239.
  22. Morton RW, Murphy KT, McKellar SR, et al. A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength in healthy adults. British Journal of Sports Medicine. 2018;52(6):376–384.
  23. Jovanovski E, Yashpal S, Komishon A, et al. Effect of psyllium (Plantago ovata) fiber on LDL cholesterol and alternative lipid targets, non-HDL cholesterol and apolipoprotein B: a systematic review and meta-analysis of randomized controlled trials. American Journal of Clinical Nutrition. 2018;108(5):922–932.
  24. Gholami Z, Paknahad Z. Psyllium supplementation and lipid profiles: systematic review and dose-response meta-analysis of randomized controlled trials. Genes & Nutrition. 2025;20:27.
  25. 21 CFR § 101.81. Health claims: soluble fiber from certain foods and risk of coronary heart disease (CHD).
  26. Manson JE, Cook NR, Lee IM, et al. Marine n-3 fatty acids and prevention of cardiovascular disease and cancer. New England Journal of Medicine. 2019;380(1):23–32.
  27. Skulas-Ray AC, Wilson PWF, Harris WS, et al. Omega-3 fatty acids for the management of hypertriglyceridemia: a science advisory from the American Heart Association. Circulation. 2019;140(12):e673–e691.
  28. Bhatt DL, Steg PG, Miller M, et al. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia (REDUCE-IT). New England Journal of Medicine. 2019;380(1):11–22.
  29. Nicholls SJ, Lincoff AM, Garcia M, et al. Effect of high-dose omega-3 fatty acids vs corn oil on major adverse cardiovascular events in patients at high cardiovascular risk: the STRENGTH randomized clinical trial. JAMA. 2020;324(22):2268–2280. See also the achieved-EPA and DHA secondary analysis, JAMA. 2021.
  30. Bostrom JA, Beckman JA, Berger JS. Summoning STRENGTH to question the placebo in REDUCE-IT. Circulation. 2021. doi:10.1161/CIRCULATIONAHA.121.054539.
  31. Gencer B, Djousse L, Al-Ramady OT, Cook NR, Manson JE, Albert CM. Effect of long-term marine ω-3 fatty acids supplementation on the risk of atrial fibrillation in randomized controlled trials of cardiovascular outcomes: a systematic review and meta-analysis. Circulation. 2021;144(25):1981–1990.
  32. Harris WS, Tintle NL, Etherton MR, Vasan RS. Erythrocyte long-chain omega-3 fatty acid levels are inversely associated with mortality and with incident cardiovascular disease: the Framingham Heart Study. Journal of Clinical Lipidology. 2018;12(3):718–727. Disclosure: the lead author founded and leads the company that markets the Omega-3 Index test.
  33. Lee SH, Moore LV, Park S, Harris DM, Blanck HM. Adults meeting fruit and vegetable intake recommendations, United States, 2019. MMWR Morbidity and Mortality Weekly Report. 2022;71(1):1–9.
  34. Lorenzoni G, Minto C, Vecchio MG, Zec S, Paolin I, Lamprecht M, Mestroni L, Gregori D. Fruit and vegetable concentrate supplementation and cardiovascular health: a systematic review from a public health perspective. Journal of Clinical Medicine. 2019;8(11):1914. Disclosure: one author is affiliated with the science institute of a manufacturer of fruit and vegetable concentrates.
  35. Gaziano JM, Sesso HD, Christen WG, et al. Multivitamins in the prevention of cancer in men: the Physicians’ Health Study II randomized controlled trial. JAMA. 2012;308(18):1871–1880.
  36. Sesso HD, Christen WG, Bubes V, et al. Multivitamins in the prevention of cardiovascular disease in men: the Physicians’ Health Study II randomized controlled trial. JAMA. 2012;308(17):1751–1760.
  37. Loftfield E, O’Connell CP, Abnet CC, et al. Multivitamin use and mortality risk in 3 prospective US cohorts. JAMA Network Open. 2024;7(6):e2418729.
  38. Baker LD, Manson JE, Rapp SR, et al. Effects of cocoa extract and a multivitamin on cognitive function: a randomized clinical trial. Alzheimer’s & Dementia. 2023;19(4):1308–1319. Yeung LK, Alschuler DM, Wall M, et al. Multivitamin supplementation improves memory in older adults: a randomized clinical trial. American Journal of Clinical Nutrition. 2023;118(1):273–282. Vyas CM, Manson JE, Sesso HD, et al. Effect of multivitamin-mineral supplementation versus placebo on cognitive function: results from the clinic subcohort of the COSMOS randomized clinical trial and meta-analysis of 3 cognitive studies within COSMOS. American Journal of Clinical Nutrition. 2024;119(3):692–701.
  39. Manson JE, Cook NR, Lee IM, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease. New England Journal of Medicine. 2019;380(1):33–44.
  40. LeBoff MS, Chou SH, Ratliff KA, et al. Supplemental vitamin D and incident fractures in midlife and older adults. New England Journal of Medicine. 2022;387(4):299–309.
  41. Neale RE, Baxter C, Romero BD, et al. The D-Health Trial: a randomised controlled trial of the effect of vitamin D on mortality. Lancet Diabetes & Endocrinology. 2022;10(2):120–128.
  42. Bischoff-Ferrari HA, Vellas B, Rizzoli R, et al. Effect of vitamin D supplementation, omega-3 fatty acid supplementation, or a strength-training exercise program on clinical outcomes in older adults: the DO-HEALTH randomized clinical trial. JAMA. 2020;324(18):1855–1868.
  43. Jolliffe DA, Camargo CA, Sluyter JD, et al. Vitamin D supplementation to prevent acute respiratory infections: systematic review and meta-analysis of stratified aggregate data. Lancet Diabetes & Endocrinology. 2025;13(4):307–320.
  44. Demay MB, Pittas AG, Bikle DD, et al. Vitamin D for the prevention of disease: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism. 2024;109(8):1907–1947.
  45. US Preventive Services Task Force. Vitamin D, calcium, or combined supplementation for the primary prevention of fractures in community-dwelling adults: US Preventive Services Task Force recommendation statement. JAMA. 2018;319(15):1592–1599. See also US Preventive Services Task Force. Vitamin D, calcium, or combined supplementation for the primary prevention of falls and fractures in community-dwelling adults: draft recommendation statement. December 17, 2024. Accessed October 2026.
  46. Berthold HK, Unverdorben S, Degenhardt R, Bulitta M, Gouni-Berthold I. Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial. JAMA. 2006;295(19):2262–2269.
  47. Gardner CD, Lawson LD, Block E, et al. Effect of raw garlic vs commercial garlic supplements on plasma lipid concentrations in adults with moderate hypercholesterolemia: a randomized clinical trial. Archives of Internal Medicine. 2007;167(4):346–353.
  48. Clegg DO, Reda DJ, Harris CL, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. New England Journal of Medicine. 2006;354(8):795–808.
  49. Sawitzke AD, Shi H, Finco MF, et al. The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial. Arthritis & Rheumatism. 2008;58(10):3183–3191.
  50. Oketch-Rabah HA, Roe AL, Rider CV, et al. United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts. Toxicology Reports. 2020;7:386–402. See also EFSA Panel on Food Additives and Nutrient Sources Added to Food. Scientific opinion on the safety of green tea catechins. EFSA Journal. 2018;16(4):5239.
  51. Stranges S, Marshall JR, Natarajan R, et al. Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Annals of Internal Medicine. 2007;147(4):217–223.
  52. 21 CFR § 101.83. Health claims: plant sterol/stanol esters and risk of coronary heart disease.
  53. Pu SY, Huang YL, Pu CM, et al. Effects of oral collagen for skin anti-aging: a systematic review and meta-analysis. Nutrients. 2023;15(9):2080. See also de Miranda RB, Weimer P, Rossi RC. Effects of hydrolyzed collagen supplementation on skin aging: a systematic review and meta-analysis. International Journal of Dermatology. 2021;60(12):1449–1461.
  54. National Institute of Diabetes and Digestive and Kidney Diseases. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury: Ashwagandha. Entry updated December 3, 2024.
  55. Hancocks N. Timeline: will authorities de-throne the King of Herbs? NutraIngredients. July 6, 2026.
  56. National Institutes of Health, Office of Dietary Supplements. Dietary supplements: what you need to know (accessed October 2026); and National Center for Complementary and Integrative Health, herbs at a glance series.
  57. Burgess HJ, Revell VL, Molina TA, Eastman CI. Human phase response curves to three days of daily melatonin: 0.5 mg versus 3.0 mg. Journal of Clinical Endocrinology and Metabolism. 2010;95(7):3325–3331.
  58. Dietary Supplement Health and Education Act of 1994, Pub. L. No. 103-417; and US Food and Drug Administration, Dietary Supplements: questions and answers.
  59. 21 CFR Part 111. Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements.
  60. Geller AI, Shehab N, Weidle NJ, et al. Emergency department visits for adverse events related to dietary supplements. New England Journal of Medicine. 2015;373(16):1531–1540.
  61. Tucker J, Fischer T, Upjohn L, Mazzera D, Kumar M. Unapproved pharmaceutical ingredients included in dietary supplements associated with US Food and Drug Administration warnings. JAMA Network Open. 2018;1(6):e183337.
  62. 21 CFR § 101.36. Nutrition labeling of dietary supplements, including subsection (c) on proprietary blends.
  63. US Food and Drug Administration. Structure/function claims: small entity compliance guide.
  64. Ronis MJJ, Pedersen KB, Watt J. Adverse effects of nutraceuticals and dietary supplements. Annual Review of Pharmacology and Toxicology. 2018;58:583–601.
  65. Lesser LI, Ebbeling CB, Goozner M, Wypij D, Ludwig DS. Relationship between funding source and conclusion among nutrition-related scientific articles. PLoS Medicine. 2007;4(1):e5.
Part Nine The Method of Listening to Your Body 16
  1. Hall KD, Ayuketah A, Brychta R, et al. Ultra-processed diets cause excess calorie intake and weight gain: an inpatient randomized controlled trial of ad libitum food intake. Cell Metabolism. 2019;30(1):67–77.
  2. Saw AE, Main LC, Gastin PB. Monitoring the athlete training response: subjective self-reported measures trump commonly used objective measures: a systematic review. British Journal of Sports Medicine. 2016;50(5):281–291.
  3. Buchheit M. Monitoring training status with HR measures: do all roads lead to Rome? Frontiers in Physiology. 2014;5:73.
  4. Wing RR, Phelan S. Long-term weight loss maintenance. American Journal of Clinical Nutrition. 2005;82(1 Suppl):222S–225S.
  5. Mountjoy M, Ackerman KE, Bailey DM, et al. 2023 International Olympic Committee’s (IOC) consensus statement on Relative Energy Deficiency in Sport (REDs). British Journal of Sports Medicine. 2023;57(17):1073–1097.
  6. Lichtman SW, Pisarska K, Berman ER, et al. Discrepancy between self-reported and actual caloric intake and exercise in obese subjects. New England Journal of Medicine. 1992;327(27):1893–1898.
  7. Rosenbaum M, Leibel RL. Adaptive thermogenesis in humans. International Journal of Obesity. 2010;34(Suppl 1):S47–S55.
  8. Nedeltcheva AV, Kilkus JM, Imperial J, Schoeller DA, Penev PD. Insufficient sleep undermines dietary efforts to reduce adiposity. Annals of Internal Medicine. 2010;153(7):435–441.
  9. Gardiner C, Weakley J, Burke LM, et al. The effect of alcohol on subsequent sleep in healthy adults: a systematic review and meta-analysis. Sleep Medicine Reviews. 2025;80:102030.
  10. Meeusen R, Duclos M, Foster C, et al. Prevention, diagnosis and treatment of the overtraining syndrome: joint consensus statement of the European College of Sport Science and the American College of Sports Medicine. European Journal of Sport Science. 2013;13(1):1–24.
  11. Sholzberg M, Hillis C, Crowther M, Selby R. Diagnosis and management of iron deficiency in females. Canadian Medical Association Journal. 2025;197(24):E680–E687.
  12. Drake C, Roehrs T, Shambroom J, Roth T. Caffeine effects on sleep taken 0, 3, or 6 hours before going to bed. Journal of Clinical Sleep Medicine. 2013;9(11):1195–1200.
  13. Edinger JD, Arnedt JT, Bertisch SM, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine. 2021;17(2):255–262.
  14. Schoenfeld BJ, Ogborn D, Krieger JW. Dose-response relationship between weekly resistance training volume and increases in muscle mass: a systematic review and meta-analysis. Journal of Sports Sciences. 2017;35(11):1073–1082.
  15. Pelland JC, Remmert JF, Robinson ZP, Hinson SR, Zourdos MC. The resistance training dose response: meta-regressions exploring the effects of weekly volume and frequency on muscle hypertrophy and strength gains. Sports Medicine. 2026;56(2):481–505. doi:10.1007/s40279-025-02344-w.
  16. Lauersen JB, Bertelsen DM, Andersen LB. The effectiveness of exercise interventions to prevent sports injuries: a systematic review and meta-analysis of randomised controlled trials. British Journal of Sports Medicine. 2014;48(11):871–877.
Part Ten Special Situations 62
  1. Cowley ES, Olenick AA, McNulty KL, Ross EZ. “Invisible sportswomen”: the sex data gap in sport and exercise science research. Women in Sport and Physical Activity Journal. 2021;29(2):146–151.
  2. Roberts BM, Nuckols G, Krieger JW. Sex differences in resistance training: a systematic review and meta-analysis. Journal of Strength and Conditioning Research. 2020;34(5):1448–1460.
  3. Tarnopolsky MA. Sex differences in exercise metabolism and the role of 17-beta estradiol. Medicine and Science in Sports and Exercise. 2008;40(4):648–654.
  4. Greendale GA, Sternfeld B, Huang M, et al. Changes in body composition and weight during the menopause transition. JCI Insight. 2019;4(5):e124865.
  5. Greendale GA, Han W, Finkelstein JS, et al. Changes in regional fat distribution and anthropometric measures across the menopause transition. Journal of Clinical Endocrinology and Metabolism. 2021;106(9):2520–2534.
  6. Greendale GA, Sowers M, Han W, et al. Bone mineral density loss in relation to the final menstrual period in a multiethnic cohort: results from the Study of Women’s Health Across the Nation (SWAN). Journal of Bone and Mineral Research. 2012;27(1):111–118.
  7. Watson SL, Weeks BK, Weis LJ, Harding AT, Horan SA, Beck BR. High-intensity resistance and impact training improves bone mineral density and physical function in postmenopausal women with osteopenia and osteoporosis: the LIFTMOR randomized controlled trial. Journal of Bone and Mineral Research. 2018;33(2):211–220.
  8. Troìa L, Garassino M, Volpicelli AI, et al. Sleep disturbance and perimenopause: a narrative review. Journal of Clinical Medicine. 2025;14(5):1479.
  9. Avis NE, Crawford SL, Greendale G, et al. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Internal Medicine. 2015;175(4):531–539.
  10. Matthews KA, Crawford SL, Chae CU, et al. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? Journal of the American College of Cardiology. 2009;54(25):2366–2373.
  11. Black KE, Matkin-Hussey P. The impact of protein in post-menopausal women on muscle mass and strength: a narrative review. Physiologia. 2024;4(3):266–285.
  12. Manson JE, Crandall CJ, Rossouw JE, et al. The Women’s Health Initiative randomized trials and clinical practice: a review. JAMA. 2024;331(20):1748–1760.
  13. The 2022 hormone therapy position statement of The North American Menopause Society Advisory Panel (NAMS, now The Menopause Society). Menopause. 2022;29(7):767–794.
  14. US Food and Drug Administration. FDA Approves Labeling Changes to Menopausal Hormone Therapy Products. FDA press announcement, February 12, 2026.
  15. Faubion SS, Kingsberg SA, Shifren JL, et al. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society (NAMS, now The Menopause Society). Menopause. 2020;27(9):976–992.
  16. McNulty KL, Elliott-Sale KJ, Dolan E, et al. The effects of menstrual cycle phase on exercise performance in eumenorrheic women: a systematic review and meta-analysis. Sports Medicine. 2020;50(10):1813–1827.
  17. Colenso-Semple LM, D’Souza AC, Elliott-Sale KJ, Phillips SM. Current evidence shows no influence of women’s menstrual cycle phase on acute strength performance or adaptations to resistance exercise training. Frontiers in Sports and Active Living. 2023;5:1054542.
  18. Sholzberg M, Hillis C, Crowther M, Selby R. Diagnosis and management of iron deficiency in females. Canadian Medical Association Journal. 2025;197(24):E680–E687.
  19. American College of Obstetricians and Gynecologists. Physical activity and exercise during pregnancy and the postpartum period. ACOG Committee Opinion No. 804. Obstetrics and Gynecology. 2020;135(4):e178–e188.
  20. Mountjoy M, Ackerman KE, Bailey DM, et al. 2023 International Olympic Committee’s (IOC) consensus statement on Relative Energy Deficiency in Sport (REDs). British Journal of Sports Medicine. 2023;57(17):1073–1097.
  21. Bauer J, Biolo G, Cederholm T, et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. Journal of the American Medical Directors Association. 2013;14(8):542–559.
  22. Deutz NEP, Bauer JM, Barazzoni R, et al. Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group. Clinical Nutrition. 2014;33(6):929–936.
  23. Mitchell WK, Williams J, Atherton P, Larvin M, Lund J, Narici M. Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and strength: a quantitative review. Frontiers in Physiology. 2012;3:260.
  24. Bergen G, Stevens MR, Burns ER. Falls and fall injuries among adults aged ≥65 years, United States, 2014. Morbidity and Mortality Weekly Report. 2016;65(37):993–998.
  25. US Preventive Services Task Force. Interventions to prevent falls in community-dwelling older adults: US Preventive Services Task Force recommendation statement. JAMA. 2024;332(1):51–57.
  26. Sherrington C, Fairhall NJ, Wallbank GK, et al. Exercise for preventing falls in older people living in the community. Cochrane Database of Systematic Reviews. 2019;1:CD012424.
  27. US Preventive Services Task Force. Interventions to prevent falls in community-dwelling older adults: US Preventive Services Task Force recommendation statement. JAMA. 2018;319(16):1696–1704.
  28. Fell J, Williams AD. The effect of aging on skeletal-muscle recovery from exercise: possible implications for aging athletes. Journal of Aging and Physical Activity. 2008;16(1):97–115.
  29. Garmany A, Yamada S, Terzic A. Longevity leap: mind the healthspan gap. NPJ Regenerative Medicine. 2021;6(1):57.
  30. Livingston G, Huntley J, Liu KY, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet. 2024;404(10452):572–628.
  31. Wood FA, Howard JP, Finegold JA, et al. N-of-1 trial of a statin, placebo, or no treatment to assess side effects. New England Journal of Medicine. 2020;383(22):2182–2184.
  32. de Jager J, Kooy A, Lehert P, et al. Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial. BMJ. 2010;340:c2181.
  33. Heidelbaugh JJ. Proton pump inhibitors and risk of vitamin and mineral deficiency: evidence and clinical implications. Therapeutic Advances in Drug Safety. 2013;4(3):125–133.
  34. Epic Research. After Nearly a Decade-Long Decrease, Testosterone Prescribing Rates Rising Again. Analysis of January 2012–June 2026 data. epicresearch.org, 2026.
  35. Feldman HA, Longcope C, Derby CA, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study. Journal of Clinical Endocrinology and Metabolism. 2002;87(2):589–598.
  36. Leproult R, Van Cauter E. Effect of 1 week of sleep restriction on testosterone levels in young healthy men. JAMA. 2011;305(21):2173–2174.
  37. Corona G, Rastrelli G, Monami M, et al. Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis. European Journal of Endocrinology. 2013;168(6):829–843.
  38. Lincoff AM, Bhasin S, Flevaris P, et al. Cardiovascular safety of testosterone-replacement therapy. New England Journal of Medicine. 2023;389(2):107–117.
  39. Snyder PJ, Bauer DC, Ellenberg SS, et al. Testosterone treatment and fractures in men with hypogonadism. New England Journal of Medicine. 2024;390(3):203–211.
  40. Cox CE. Testosterone doesn’t cause CV events in high-risk men with hypogonadism. TCTMD. June 16, 2023. https://www.tctmd.com/news/testosterone-doesnt-cause-cv-events-high-risk-men-hypogonadism
  41. US Food and Drug Administration. FDA issues class-wide labeling changes for testosterone products. February 28, 2025. https://www.fda.gov/drugs/drug-safety-and-availability/fda-issues-class-wide-labeling-changes-testosterone-products
  42. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism. 2018;103(5):1715–1744.
  43. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. Journal of Urology. 1984;132(3):474–479.
  44. Montero A, Kearney A, Mulugeta M, Kirzinger A, Hamel L. KFF Health Tracking Poll: prescription drug costs, views on Trump administration actions, and GLP-1 use. KFF; November 14, 2025.
  45. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine. 2021;384(11):989–1002.
  46. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine. 2022;387(3):205–216.
  47. Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes. New England Journal of Medicine. 2023;389(24):2221–2232.
  48. Gardner CD, Trepanowski JF, Del Gobbo LC, et al. Effect of low-fat vs low-carbohydrate diet on 12-month weight loss in overweight adults and the association with genotype pattern or insulin secretion: the DIETFITS randomized clinical trial. JAMA. 2018;319(7):667–679.
  49. Prado CM, Phillips SM, Gonzalez MC, Heymsfield SB. Muscle matters: the effects of medically induced weight loss on skeletal muscle. Lancet Diabetes and Endocrinology. 2024;12(11):785–787.
  50. Almandoz JP, Wadden TA, Tewksbury C, et al. Nutritional considerations with antiobesity medications. Obesity. 2024;32(9):1613–1631.
  51. Mozaffarian D, Agarwal M, Aggarwal M, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association and The Obesity Society. Obesity. 2025;33(8):1475–1503.
  52. Cava E, Yeat NC, Mittendorfer B. Preserving healthy muscle during weight loss. Advances in Nutrition. 2017;8(3):511–519.
  53. Lundgren JR, Janus C, Jensen SBK, et al. Healthy weight loss maintenance with exercise, liraglutide, or both combined. New England Journal of Medicine. 2021;384(18):1719–1730.
  54. Wilding JPH, Batterham RL, Davies M, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes, Obesity and Metabolism. 2022;24(8):1553–1564.
  55. Aronne LJ, Sattar N, Horn DB, et al. Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial. JAMA. 2024;331(1):38–48.
  56. Friedrichsen M, Breitschaft A, Tadayon S, et al. The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity. Diabetes, Obesity and Metabolism. 2021;23(3):754–762.
  57. Novo Nordisk Inc. FDA approves Ozempic (semaglutide) to reduce the risk of kidney disease worsening, kidney failure and death due to cardiovascular disease in adults with type 2 diabetes and chronic kidney disease. Press release, January 28, 2025. https://www.ozempic.com/content/dam/diabetes-patient/ozempic/pdfs/OzempicCKDsNDAPressReleaseJanuary282025.pdf
  58. Sanyal AJ, Newsome PN, Kliers I, et al. Phase 3 trial of semaglutide in metabolic dysfunction-associated steatohepatitis. New England Journal of Medicine. 2025;392(21):2089–2099. FDA accelerated approval of semaglutide 2.4 mg for noncirrhotic MASH with moderate to advanced fibrosis, August 15, 2025.
  59. Novo Nordisk A/S. Wegovy pill approved in the US as first oral GLP-1 for weight management. Press release, December 22, 2025. https://www.biospace.com/press-releases/novo-nordisk-a-s-wegovy-pill-approved-in-the-us-as-first-oral-glp-1-for-weight-management
  60. HCPLive. FDA approves orforglipron (Foundayo) as first daily GLP-1 pill without food or water restrictions. April 1, 2026. https://www.hcplive.com/view/fda-approves-orforglipron-foundayo-as-first-daily-glp-1-pill-without-food-water-restrictions
  61. Centers for Medicare & Medicaid Services. Medicare GLP-1 Bridge (July 1, 2026 to December 31, 2027). cms.gov, updated July 2026. See also the White House announcement of pricing agreements with Eli Lilly and Novo Nordisk, November 6, 2025.
  62. US Food and Drug Administration. FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize. fda.gov, 2025. https://www.fda.gov/drugs/drug-safety-and-availability/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize
Part Eleven Putting It Together 10
  1. Ross R, Neeland IJ, Yamashita S, et al. Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity. Nature Reviews Endocrinology. 2020;16(3):177–189.
  2. Morton RW, Murphy KT, McKellar SR, et al. A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength in healthy adults. British Journal of Sports Medicine. 2018;52(6):376–384.
  3. Wing RR, Phelan S. Long-term weight loss maintenance. American Journal of Clinical Nutrition. 2005;82(1 Suppl):222S–225S.
  4. Ding D, Nguyen B, Nau T, et al. Daily steps and health outcomes in adults: a systematic review and dose–response meta-analysis. The Lancet Public Health. 2025;10(8):e668–e681.
  5. Reynolds A, Mann J, Cummings J, Winter N, Mete E, Te Morenga L. Carbohydrate quality and human health: a series of systematic reviews and meta-analyses. The Lancet. 2019;393(10170):434–445.
  6. Schoenfeld BJ, Ogborn D, Krieger JW. Effects of resistance training frequency on measures of muscle hypertrophy: a systematic review and meta-analysis. Sports Medicine. 2016;46(11):1689–1697.
  7. Watson NF, Badr MS, Belenky G, et al. Recommended amount of sleep for a healthy adult: a joint consensus statement of the American Academy of Sleep Medicine and Sleep Research Society. Sleep. 2015;38(6):843–844.
  8. Drake C, Roehrs T, Shambroom J, Roth T. Caffeine effects on sleep taken 0, 3, or 6 hours before going to bed. Journal of Clinical Sleep Medicine. 2013;9(11):1195–1200.
  9. Balban MY, Neri E, Kogon MM, Zeitzer JM, Spiegel D, Huberman AD. Brief structured respiration practices enhance mood and reduce physiological arousal. Cell Reports Medicine. 2023;4(1):100895.
  10. Weigle DS, Breen PA, Matthys CC, et al. A high-protein diet induces sustained reductions in appetite, ad libitum caloric intake, and body weight despite compensatory changes in diurnal plasma leptin and ghrelin concentrations. American Journal of Clinical Nutrition. 2005;82(1):41–48.

How the references were chosen: the book cites the primary source rather than coverage of it. Where a claim rests on a meta-analysis, the meta-analysis is cited, and where the result is contested, at least one trial that disagrees. Observational findings are labeled as observational in the text.

If you find a source that has been characterized incorrectly, Gerry would like to know. Get in touch at gerrymorton.com.